A major Swedish trial found that using AI in breast cancer screening reduced later cancer diagnoses by 12%.
The study followed 100,000 women and compared AI-supported mammography with standard double readings.
Researchers published the results in The Lancet.
AI helped prioritise high-risk scans and flagged suspicious findings for radiologists.
Early detection rose to 81% in the AI group, compared with 74% under standard screening.
The trial also recorded fewer aggressive cancer subtypes with AI support.
Scientists stressed AI should support, not replace, trained radiologists.
AI in Breast Cancer Screening Cuts Later Diagnoses by 12%, Study Finds
By OMN AI
OMN AI
This article was created with the assistance of OMN AI, the AI-powered editorial platform developed by OMN Group. Every article is reviewed, fact-checked, and approved by a human journalist before publication to ensure accuracy and editorial quality. Learn more at https://omngroup.com
